Wenjuan Liu
1111 XianXia Road
Shanghai, 200336, China
Shanghai, 200336, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
2,3-Diphosphoglyceric Acid Alleviating Hypoxic-Ischemic Brain Damage through p38 MAPK Modulation.
Journal: International journal of molecular sciences
Published: May 30, 2024
Metabolomics analysis revealed the neuroprotective role of 2-phosphoglyceric acid in hypoxic-ischemic brain damage through GPX4/ACSL4 axis regulation.
Journal: European journal of pharmacology
Published: January 08, 2024
BMAL1 deletion protects against obesity and non-alcoholic fatty liver disease induced by a high-fat diet.
Journal: International journal of obesity (2005)
Published: September 24, 2023
Exploring the underlying mechanisms of Ashitaba in the management of non-alcoholic fatty liver disease by integrating the analysis of transcriptomics and metabolomics.
Journal: Frontiers in medicine
Published: June 26, 2023
Systemic Klotho therapy protects against insulitis and enhances beta-cell mass in NOD mice.
Journal: Biochemical and biophysical research communications
Published: February 05, 2020
Combined effect of GABA and glucagon-like peptide-1 receptor agonist on cytokine-induced apoptosis in pancreatic β-cell line and isolated human islets.
Journal: Journal of diabetes
Published: August 17, 2018
The anti-aging protein Klotho is induced by GABA therapy and exerts protective and stimulatory effects on pancreatic beta cells.
Journal: Biochemical and biophysical research communications
Published: October 03, 2017
Novel GLP-1 Analog Supaglutide Reduces HFD-Induced Obesity Associated with Increased Ucp-1 in White Adipose Tissue in Mice.
Journal: Frontiers in physiology
Published: March 02, 2017
Combined Oral Administration of GABA and DPP-4 Inhibitor Prevents Beta Cell Damage and Promotes Beta Cell Regeneration in Mice.
Journal: Frontiers in pharmacology
Published: February 25, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026